California surgical assistance solutions maker Patient Safety Technologies (OTC:PSTX) earlier this year leveled a lawsuit against rival device maker ClearCount Medical Solutions, the company noted in its latest earnings report.
ClearCount Medical Solutions
Medtronic lands Japanese approval for CoreValve trial | Regulatory Roundup
Medtronic (NYSE:MDT) implanted its CoreValve transcatheter aortic valve implantation system into the first patient in a Japanese clinical trial of the device’s safety and effectiveness.
The CoreValve system is a minimally invasive treatment option for patients with severe heart disease who are at high risk or unable to undergo open-heart surgery.
ClearCount Medical rings in a $5 million Series B round
ClearCount Medical Solutions Inc. closed its Series B funding round with a hoped-for $5 million.
ClearCount is developing the SmartSponge and SmartWand systems, which use radio-frequency identification technology and chips embedded in sponges to allow surgeons and nurses to detect and count sponges during surgeries.
ClearCount raises $1.1 million in Series B round
ClearCount Medical Solutions Inc. raised $1.1 million in the first tranche of a Series B funding round it hopes will total $5 million.
The funding was detailed in a regulatory filing and confirmed by CFO Dave Haffner.
MedCity News Q&A: Clearcount Medical Solutions CEO David Palmer
David Palmer thinks ClearCount Medical Solutions’ technology will push it over the top in the burgeoning surgical sponge detection market.
ClearCount appoints new CFO
Sponge safety company ClearCount Medical Solutions hired David Haffner to be its new CFO.
Haffner, who was CFO for medical technology companies including RedPath Integrated Pathology and Renal Solutions, will oversee the day-to-day financial operations of Pittsburgh-based ClearCount and will be responsible for its financial strategy, according to a press release.